Red Flag One: In her last 12 years of employment (excluding Starpharma) CM has had 10 different jobs with 5 different employers. Five of these jobs lasted for 1 year and 1 month or less.
*Some might say this is a good thing for breadth of experience. However in my experience, I have found that habitual job-hoppers are not the type of key people you want in a company.
Red Flag Two: CM’s introductory letter to shareholders seemed to be drowning in platitudes, motherhood statements and vanilla corporate buzzwords and phrases. This doesn’t strike me as someone who is going to take a much needed sledgehammer to this laggard corporate performer.
Red Flag Three: The first deal announced under CM’s watch was a no-licence fee, and apparent no minimum annual volume ‘deal’ for VivaGel with ITROM for MENA. It was such an underwhelming announcement and I can’t believe it was marked up a price-sensitive. *Granted, the nuts and bolts of this impotent deal were likely worked out prior to her commencing as CEO, but nonetheless, the deal was consummated and announced on her watch.
Reg Flag Four: The lack of detail in the Viraleze post-market trial announcement.
Red Flag Five: The seemingly woefully inadequate clarity and future guidance regarding the recently submitted FDA formal appeal, including timelines, decision dates, and possible implications for the company.
All this in her first 5 weeks at the helm. So far IMO, it doesn’t seem like a breath of fresh air at HQ, it’s just more of the same. The jury is still out.
P.S. Next hurdle (the tiniest hurdle possible) is to deliver a February update like she told shareholders she would be doing. She said this only last month. 16 days to go. CM even gets one extra day to deliver due to the leap year lol.
P.S.S. Any counterpoints, logical rebuttal and debate to this post are most welcome. On the other hand, any one sentence, lazy and thoughtless pot shots at me will be ignored.
P.S.S. Numbers and stats in this post were collated with best endeavours and may be subject to error. All statements IMO only.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)